Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fong, L. Y. Y.
Right arrow Articles by Pegg, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fong, L. Y. Y.
Right arrow Articles by Pegg, A. E.
[Cancer Research 63, 3945-3954, July 15, 2003]
© 2003 American Association for Cancer Research

Carcinogenesis

Antizyme Overexpression in Transgenic Mice Reduces Cell Proliferation, Increases Apoptosis, and Reduces N-Nitrosomethylbenzylamine-induced Forestomach Carcinogenesis1

Louise Y. Y. Fong, David J. Feith and Anthony E. Pegg2

Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 [L. Y. Y. F.], and Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033 [D. J. F., A. E. P.]

Antizyme (AZ) is known to be a regulator of polyamine metabolism that inhibits ornithine decarboxylase activity and polyamine transport, thus restricting polyamine levels. Transgenic mice with AZ expression targeted to the basal cell layer of the forestomach epithelium by the keratin 5 promoter were used to investigate whether AZ overexpression inhibited uncontrolled cell proliferation in zinc-deficient (ZD) mice and reduced their susceptibility to forestomach carcinogenesis by N-nitrosomethylbenzylamine (NMBA). Four-week-old keratin 5/AZ and wild-type (Wt) littermates were placed on ZD or zinc-sufficient (ZS) diets to form four groups: ZD:AZ, ZD:Wt, ZS:AZ, and ZS:Wt. After 5 weeks, 27–45 mice in each group were treated twice with NMBA and sacrificed 14 weeks later. Independent of zinc intake, AZ mice had significantly lower forestomach tumor incidence and tumor multiplicity than respective Wt littermates (P < 0.001): 21% of ZD:AZ versus 76% of ZD:Wt mice and 3% of ZS:AZ versus 33% of ZS:Wt mice developed tumors. Spermidine content was reduced in NMBA-treated ZD:AZ forestomachs. Zinc deficiency increased the forestomach cell proliferation in Wt mice, but this effect was blocked by AZ. Conversely, apoptosis was substantially higher in control and NMBA-treated ZD:AZ than respective ZD:Wt forestomachs. The restored ZD:AZ forestomach epithelium displayed strong expression of Bax, a proapoptotic protein, and weak staining of cyclin D1 and its catalytic partner Cdk4, key regulatory proteins controlling G1 to S progression. In contrast, proliferative ZD:Wt forestomach showed strong expression of Bcl-2, an antiapoptotic protein, and overexpression of cyclin D1/Cdk4. Treatment of ZD:Wt mice with {alpha}-difluoromethylornithine, an inhibitor of ornithine decarboxylase, had similar results to AZ in reducing tumor incidence, spermidine content, decreasing cell proliferation, and increasing apoptosis. These results demonstrate that AZ may act as a tumor suppressor gene stimulating apoptosis and restraining cell proliferation, thereby inhibiting forestomach tumor development. Although effects of AZ on functions other than polyamine metabolism are possible, alterations in polyamines are the most likely explanation for the reduction in tumors, supporting the use of strategies to modulate polyamine levels for cancer chemoprevention in individuals at high risk of developing malignancies of the gastrointestinal tract.




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
I. P. Ivanov and J. F. Atkins
Ribosomal frameshifting in decoding antizyme mRNAs from yeast and protists to humans: close to 300 cases reveal remarkable diversity despite underlying conservation
Nucleic Acids Res., March 19, 2007; 35(6): 1842 - 1858.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. J. Lopez-Contreras, C. Lopez-Garcia, C. Jimenez-Cervantes, A. Cremades, and R. Penafiel
Mouse Ornithine Decarboxylase-like Gene Encodes an Antizyme Inhibitor Devoid of Ornithine and Arginine Decarboxylating Activity
J. Biol. Chem., October 13, 2006; 281(41): 30896 - 30906.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
S. W. Kim, U. Mangold, C. Waghorne, A. Mobascher, L. Shantz, J. Banyard, and B. R. Zetter
Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism
J. Cell Sci., June 15, 2006; 119(12): 2583 - 2591.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. E. Pegg
Regulation of Ornithine Decarboxylase
J. Biol. Chem., May 26, 2006; 281(21): 14529 - 14532.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. J. Feith, S. Origanti, P. L. Shoop, S. Sass-Kuhn, and L. M. Shantz
Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis
Carcinogenesis, May 1, 2006; 27(5): 1090 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-G. Liu, L. Zhang, Y. Jiang, D. Chatterjee, C. M. Croce, K. Huebner, and L. Y.Y. Fong
Modulation of Gene Expression in Precancerous Rat Esophagus by Dietary Zinc Deficit and Replenishment
Cancer Res., September 1, 2005; 65(17): 7790 - 7799.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. J. Feith, D. K. Bol, J. M. Carboni, M. J. Lynch, S. Sass-Kuhn, P. L. Shoop, and L. M. Shantz
Induction of Ornithine Decarboxylase Activity Is a Necessary Step for Mitogen-Activated Protein Kinase Kinase-Induced Skin Tumorigenesis
Cancer Res., January 15, 2005; 65(2): 572 - 578.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. Y. Y. Fong, L. Zhang, Y. Jiang, and J. L. Farber
Dietary Zinc Modulation of COX-2 Expression and Lingual and Esophageal Carcinogenesis in Rats
J Natl Cancer Inst, January 5, 2005; 97(1): 40 - 50.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A.-T. Vlastos, L. A. West, E. N. Atkinson, I. Boiko, A. Malpica, W. K. Hong, and M. Follen
Results of a Phase II Double-Blinded Randomized Clinical Trial of Difluoromethylornithine for Cervical Intraepithelial Neoplasia Grades 2 to 3
Clin. Cancer Res., January 1, 2005; 11(1): 390 - 396.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. M. Newman, A. Mobascher, U. Mangold, C. Koike, S. Diah, M. Schmidt, D. Finley, and B. R. Zetter
Antizyme Targets Cyclin D1 for Degradation: A NOVEL MECHANISM FOR CELL GROWTH REPRESSION
J. Biol. Chem., October 1, 2004; 279(40): 41504 - 41511.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Y. Y. Fong, R. Mancini, H. Nakagawa, A. K. Rustgi, and K. Huebner
Combined Cyclin D1 Overexpression and Zinc Deficiency Disrupts Cell Cycle and Accelerates Mouse Forestomach Carcinogenesis
Cancer Res., July 15, 2003; 63(14): 4244 - 4252.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.